ArticleProceedings of the National Academy of Sciences of the United States of America2021

CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.

Thomas Naert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.